T-cell based immunotherapies for Parkinson’s disease
Current evidence indicates that neurodegeneration of dopaminergic neurons of the substantia nigra associated to Parkinson’s disease is a consequence of a neuroinflammatory process in which microglial cells play a central role. The initial activation of microglial cells is triggered by pathogenic pro...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2021-10-01
|
Series: | Exploration of Neuroprotective Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/ent/Article/10047 |